News

Alkermes Welcomes Financial Expert Joshua Reed as CFO

Alkermes Welcomes Financial Expert Joshua Reed as CFO

Alkermes Appoints Joshua Reed as Chief Financial Officer

Alkermes plc (Nasdaq: ALKS) is excited to announce the newest addition to its leadership team with the appointment of Joshua Reed as Chief Financial Officer (CFO). This key decision reflects a strategic move to enhance the company’s financial operations while advancing its innovative initiatives.

Experience and Vision for Alkermes

With over three decades of financial expertise focused primarily in the biotechnology and pharmaceutical sectors, Joshua Reed brings a wealth of knowledge to Alkermes. His prior role as CFO for Omega Therapeutics marks a significant achievement in his career, where he excelled in financial management for a publicly-traded biotechnology company. Additionally, Reed served at Aldeyra Therapeutics before that, gaining valuable experiences that enhance his qualification for the role at Alkermes.

Strong Background in the Industry

Before joining Alkermes, Reed contributed significantly at Bristol Myers Squibb, where he held the position of Vice President and Head of Finance Operations in the U.S. and Puerto Rico. He has also cultivated financial expertise through roles at prominent financial institutions, including JPMorgan Chase, Credit Suisse First Boston, and Chase Manhattan Bank.

Looking Forward to Future Growth

Commenting on his new role, Joshua Reed expressed enthusiasm, stating, "I am delighted to be joining Alkermes and look forward to collaborating with Richard and the team. Together, we aim to build upon Alkermes' strong financial foundation and align our financial strategy with the company's goals for operational excellence and innovative growth." This spirit of collaboration is crucial as Alkermes finds itself at pivotal moments in its evolution.

Commitment to Delivering Shareholder Value

Richard Pops, Chief Executive Officer of Alkermes, welcomed Joshua Reed during this exciting chapter for the company. He emphasized the importance of Reed’s extensive financial background and his dedication to excellence, stating, "His financial acumen will play a pivotal role in advancing our pipeline and enhancing performance across our commercial operations. We are committed to maximizing long-term shareholder value, and I am confident Joshua will have a significant positive impact on our organization.

A Vision for Innovative Medicines

Alkermes plc, a mid-cap growth and value equity company listed on Nasdaq under the ticker ALKS, is dedicated to developing innovative biopharmaceutical solutions, particularly in neuroscience. Their proprietary commercial products target severe conditions such as alcohol and opioid dependence, schizophrenia, and bipolar I disorder. With a varied portfolio, the company is advancing numerous clinical and preclinical candidates aimed at treating neurological disorders like narcolepsy and idiopathic hypersomnia.

Headquartered in Ireland, Alkermes maintains a robust presence with facilities for research and development located in Massachusetts, alongside a manufacturing plant situated in Ohio. The company continues to prioritize designing and implementing groundbreaking therapies that respond to complex medical needs.

Connecting with Alkermes

As Alkermes moves ahead, the company remains accessible for inquiries regarding investment and media relations. For investors, they offer a direct line through Sandy Coombs at +1 781 609 6377, while media inquiries can be directed to Katie Joyce at +1 781 249 8927. This commitment to transparency ensures that stakeholders are well-informed about upcoming advancements and initiatives.

Frequently Asked Questions

Who is Joshua Reed?

Joshua Reed is the newly appointed Chief Financial Officer of Alkermes plc, bringing over 30 years of financial leadership experience in biotechnology.

What are Joshua Reed's past roles?

Before joining Alkermes, Reed served as CFO of Omega Therapeutics and Aldeyra Therapeutics, among other significant positions at major institutions.

What is the focus of Alkermes plc?

Alkermes is a biopharmaceutical company focused on developing innovative medicines in the neuroscience field, particularly for psychiatric and neurological conditions.

How can investors contact Alkermes?

Investors can reach out to Sandy Coombs at +1 781 609 6377 for any inquiries regarding investments in Alkermes.

What is the mission of Alkermes?

The mission of Alkermes is to deliver transformative medicines for complex diseases, ensuring that they meet the diverse needs of patients and enhance health outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 152

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 157

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 84

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 227

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 111

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 182

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 26

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 135

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Rush to ExoraPad: The Rise of $EXP Tokens Explained

Updated Category News Views 219

Investors Flock to ExoraPad as the $EXP Token Presale Surges As the digital currency landscape evolves, many investors are seeking the next big opportunity. ExoraPad has emerged as a focal point in this space, particularly for those involved with XRP. The ongoing presale for the $EXP token has garnered immense attention, attracting numerous investors eager to secure their...

Continue Reading
Key Insights on DFDS A/S Share Transactions Involving Managers

Updated Category News Views 251

Recent Share Transactions by DFDS A/S Leadership On February 25, a significant transaction was recorded involving Claus V. Hemmingsen, the Chair of the Board of Directors for DFDS A/S, who purchased 5,000 shares of the company. This action showcases the confidence of the company’s leadership in its growth trajectory and operational strategy. Regulatory Obligations Under...

Continue Reading
First Guaranty Bancshares Reaches New Stock Milestone

Updated Category News Views 253

First Guaranty Bancshares Achieves New Milestone First Guaranty Bancshares Inc (NASDAQ: FGBI) has recently achieved a notable milestone, with its stock hitting a new 52-week high of $13.38. This impressive leap highlights a phase of robust growth for the company, reflected in the rising stock price that has been buoyed by favorable market sentiments. Over the past year,...

Continue Reading
Pho Hoa & Jazen Tea Expands Southeast with New Location

Updated Category News Views 314

Pho Hoa & Jazen Tea Expands into the Southeast Pho Hoa & Jazen Tea is excited to announce the grand opening of a new restaurant in Marietta, marking an important milestone in the brand's expansion strategy. With over 40 years dedicated to perfecting pho noodle soup, the company is eager to bring its incredible Vietnamese culinary experience to new customers. Exciting New...

Continue Reading
IDT Corporation's Commitment to Shareholders with New Dividend

Updated Category News Views 74

IDT Corporation Announces Quarterly Dividend for Shareholders IDT Corporation (NYSE: IDT), a key player in communications and payment services, has recently made waves by declaring a quarterly cash dividend of $0.05 per share. This news was shared through a regulatory filing, illustrating the company's ongoing commitment to providing value to its shareholders. Details on...

Continue Reading